Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 14/20 | 0.74 |
| ▸ | CCNB2 | O95067 | 13/20 | 0.74 |
| ▸ | CCNB1 | P14635 | 13/20 | 0.74 |
| ▸ | CCNB3 | Q8WWL7 | 13/20 | 0.74 |
| ▸ | JAK1 | P23458 | 6/20 | 0.74 |
| ▸ | TYK2 | P29597 | 6/20 | 0.74 |
| ▸ | CDK2 | P24941 | 5/20 | 0.74 |
| ▸ | JAK3 | P52333 | 5/20 | 0.74 |
| ▸ | JAK2 | O60674 | 5/20 | 0.74 |
| ▸ | CDK4 | P11802 | 4/20 | 0.74 |
| ▸ | CCNA2 | P20248 | 4/20 | 0.74 |
| ▸ | CCND1 | P24385 | 4/20 | 0.74 |
| ▸ | MAPK3 | P27361 | 4/20 | 0.74 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.74 |
| ▸ | KDR | P35968 | 4/20 | 0.74 |
| ▸ | GSK3A | P49840 | 4/20 | 0.74 |
| ▸ | GSK3B | P49841 | 4/20 | 0.74 |
| ▸ | CCNA1 | P78396 | 4/20 | 0.74 |
| ▸ | FGFR2 | P21802 | 3/20 | 0.74 |
| ▸ | CSNK1A1 | P48729 | 3/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5727292 | 0.90 | CDK1 (0.83) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL5727275 | 0.87 | CDK1 (0.79) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL5725430 | 0.86 | CDK1 (0.84) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| Jnj-7706621 SCHEMBL1060773 | 0.86 | CDK1 (1.00) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL5726847 | 0.85 | CDK1 (0.86) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL5727451 | 0.84 | CDK1 (0.80) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL5727313 | 0.84 | CDK1 (0.80) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL5964778 | 0.83 | CCNB2 (0.71) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL5726498 | 0.82 | CDK1 (0.71) | CDK1CCNB2CCNB1CCNB3JAK1 | |
| SCHEMBL14288375 | 0.82 | CDK1 (0.73) | CDK1CCNB2CCNB1CCNB3JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1355889-B1 | SUBSTITUTED TRIAZOLE DIAMINE DERIVATIVES AS KINASE INHIBITORS | ORTHO MCNEIL PHARM INC (US) | 2006-06-07 | — | — | EP | claimed |
| US-6924302-B2 | Substituted triazole diamine derivatives as kinase inhibitors | ORTHO MCNEIL PHARMACEUTICAL, INC. (US) | 2005-08-02 | — | — | US | claimed |
| CN-1575284-A | Substituted triazole diamine derivatives as kinase inhibitors | ORTHO MCNEIL PHARM INC (US) | 2005-02-02 | — | — | CN | claimed |
| US-20040077699-A1 | Substituted triazole diamine derivatives as kinase inhibitors | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-04-22 | — | — | US | claimed |
| EP-1355889-A1 | SUBSTITUTED TRIAZOLE DIAMINE DERIVATIVES AS KINASE INHIBITORS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-10-29 | — | — | EP | claimed |
| WO-2002057240-A1 | SUBSTITUTED TRIAZOLE DIAMINE DERIVATIVES AS KINASE INHIBITORS | ORTHO MC NEIL PHARMACEUTICAL, INC. (US) | 2002-07-25 | — | — | WO | claimed |
| EP-1712550-A2 | Substituted triazole diamine derivatives as kinase inhibitors | Ortho-McNeil Pharmaceutical, Inc. (US) | 2006-10-18 | — | — | EP | disclosed |
| EP-1355889-B1 | SUBSTITUTED TRIAZOLE DIAMINE DERIVATIVES AS KINASE INHIBITORS | ORTHO MCNEIL PHARM INC (US) | 2006-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040077699-A1 | Substituted triazole diamine derivatives as kinase inhibitors | MAP2K2, PRKDC, MAP2K3 | CDK1 387/4885CCNB2 2020/4885CCNB1 2548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.